-
1
-
-
0022636142
-
-
Page, E.H.; Wexler, D.M.; Guenther, L.C. Cyclosporin A. J. Am. Acad. Dermatol., 1986, 14(5), 785-791.
-
(1986)
Am. Acad. Dermatol
, vol.14
, Issue.5
, pp. 785-791
-
-
Page, E.H.1
Wexler, D.M.2
Guenther, L.C.3
Cyclosporin, A.J.4
-
2
-
-
84884044858
-
-
xPharm: The Comprehensive Pharmacology Reference; Elsevier: New York
-
Scholar, E.; Enna, S.J.; David, B.B. Cyclosporin. In xPharm: The Comprehensive Pharmacology Reference; Elsevier: New York, 2007, pp. 1-8.
-
(2007)
Cyclosporin
, pp. 1-8
-
-
Scholar, E.1
Enna, S.J.2
David, B.B.3
-
3
-
-
0028820208
-
Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine
-
Wu, C.Y.; Benet, L.Z.; Hebert, M.F.; Gupta, S.K.; Rowland, M.; Gomez, D.Y.; Wacher, V.J. Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine. Clin. Pharmacol. Ther., 1995, 58(5), 492-497.
-
(1995)
Clin. Pharmacol. Ther
, vol.58
, Issue.5
, pp. 492-497
-
-
Wu, C.Y.1
Benet, L.Z.2
Hebert, M.F.3
Gupta, S.K.4
Rowland, M.5
Gomez, D.Y.6
Wacher, V.J.7
-
4
-
-
0033134854
-
Considerations concerning generic formulations of immunosuppressive drugs
-
Kahan, B.D. Considerations concerning generic formulations of immunosuppressive drugs. Transpl. Proc., 1999, 31(3), 1635-1641.
-
(1999)
Transpl. Proc
, vol.31
, Issue.3
, pp. 1635-1641
-
-
Kahan, B.D.1
-
5
-
-
0030803356
-
Switching between cyclosporine formulations. What are the risks?
-
Olyaei, A.J.; deMattos, A.M.; Bennett, W.M. Switching between cyclosporine formulations. What are the risks? Drug Saf., 1997, 16(6), 366-373.
-
(1997)
Drug Saf
, vol.16
, Issue.6
, pp. 366-373
-
-
Olyaei, A.J.1
Demattos, A.M.2
Bennett, W.M.3
-
6
-
-
0029017526
-
Percutaneous absorption and dermal delivery of cyclosporin
-
Choi, H.K.; Flynn, G.L.; Amidon, G.L. Percutaneous absorption and dermal delivery of cyclosporin A. J. Pharm. Sci., 1995, 84(5), 581-583.
-
(1995)
A. J. Pharm. Sci
, vol.84
, Issue.5
, pp. 581-583
-
-
Choi, H.K.1
Flynn, G.L.2
Amidon, G.L.3
-
7
-
-
15544362279
-
Polymeric particulates to improve oral bioavailability of peptide drugs
-
Delie, F.; Blanco-Prieto, M.J. Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules, 2005, 10(1), 65-80.
-
(2005)
Molecules
, vol.10
, Issue.1
, pp. 65-80
-
-
Delie, F.1
Blanco-Prieto, M.J.2
-
8
-
-
0027223598
-
Formation and characterization of cyclosporine-loaded nanoparticles
-
Guzman, M.; Molpeceres, J.; Garcia, F.; Aberturas, M.R.; Rodriguez, M. Formation and characterization of cyclosporine-loaded nanoparticles. J. Pharm. Sci., 1993, 82(5), 498-502.
-
(1993)
J. Pharm. Sci
, vol.82
, Issue.5
, pp. 498-502
-
-
Guzman, M.1
Molpeceres, J.2
Garcia, F.3
Aberturas, M.R.4
Rodriguez, M.5
-
9
-
-
0027383302
-
Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A
-
Sánchez, A.; Vila-Jato, J.; Alonso, M.J. Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A. Int. J. Pharm., 1993, 99(2-3), 263-273.
-
(1993)
Int. J. Pharm
, vol.99
, Issue.2-3
, pp. 263-273
-
-
Sánchez, A.1
Vila-Jato, J.2
Alonso, M.J.3
-
10
-
-
0030572633
-
Optimized preparation of poly (lactic-glycolic) microspheres and nanoparticles for oral administration
-
Chacón, M.; Berges, L.; Molpeceres, J.; Aberturas, M.R.; Guzman, M. Optimized preparation of poly (lactic-glycolic) microspheres and nanoparticles for oral administration. Int. J. Pharm., 1996, 141(1-2), 81-91.
-
(1996)
Int. J. Pharm
, vol.141
, Issue.1-2
, pp. 81-91
-
-
Chacón, M.1
Berges, L.2
Molpeceres, J.3
Aberturas, M.R.4
Guzman, M.5
-
11
-
-
0032850436
-
Polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy
-
Molpeceres, J.; Chacón, M.; Guzmán, M.; Berges, L.; del Rosario Aberturas, M. A polycaprolactone nanoparticle formulation of cyclosporin-A improves the prediction of area under the curve using a limited sampling strategy. Int. J. Pharm., 1999, 187(1), 101-113.
-
(1999)
Int. J. Pharm
, vol.187
, Issue.1
, pp. 101-113
-
-
Molpeceres, J.1
Chacón, M.2
Guzmán, M.3
Berges, L.4
Del, R.5
Aberturas, M.A.6
-
12
-
-
0037028069
-
Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer
-
Lee, W.-K.; Park, J.-Y.; Yang, E.H.; Suh, H.; Kim, S.H.; Chung, D.S.; Choi, K.; Yang, C.W.; Park, J.-S. Investigation of the factors influencing the release rates of cyclosporin A-loaded micro- and nanoparticles prepared by high-pressure homogenizer. J. Control. Release, 2002, 84(3), 115-123.
-
(2002)
J. Control. Release
, vol.84
, Issue.3
, pp. 115-123
-
-
Lee, W.-K.1
Park, J.-Y.2
Yang, E.H.3
Suh, H.4
Kim, S.H.5
Chung, D.S.6
Choi, K.7
Yang, C.W.8
Park, J.-S.9
-
13
-
-
1842525943
-
Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process
-
Jaiswal, J.; Kumar Gupta, S.; Kreuter, J. Preparation of biodegradable cyclosporine nanoparticles by high-pressure emulsification-solvent evaporation process. J. Control. Release, 2004, 96(1), 169-178.
-
(2004)
J. Control. Release
, vol.96
, Issue.1
, pp. 169-178
-
-
Jaiswal, J.1
Kumar, G.S.2
Kreuter, J.3
-
14
-
-
0037027833
-
Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A
-
El-Shabouri, M.H. Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A. Int. J. Pharm., 2002, 249(1-2), 101-108.
-
(2002)
Int. J. Pharm
, vol.249
, Issue.1-2
, pp. 101-108
-
-
El-Shabouri, M.H.1
-
15
-
-
32244438967
-
Design of estradiol loaded PLGA nanoparticulate formulations: A potential oral delivery system for hormone therapy
-
Hariharan, S.; Bhardwaj, V.; Bala, I.; Sitterberg, J.; Bakowsky, U.; Ravi Kumar, M.N. Design of estradiol loaded PLGA nanoparticulate formulations: a potential oral delivery system for hormone therapy. Pharm. Res., 2006, 23(1), 184-195.
-
(2006)
Pharm. Res
, vol.23
, Issue.1
, pp. 184-195
-
-
Hariharan, S.1
Bhardwaj, V.2
Bala, I.3
Sitterberg, J.4
Bakowsky, U.5
Ravi, K.M.N.6
-
16
-
-
34249087392
-
PLGA nanoparticles for oral delivery of cyclosporine: Ne.phrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral®
-
Italia, J.L.; Bhatt, D.K.; Bhardwaj, V.; Tikoo, K.; Kumar, M.N.V.R. PLGA nanoparticles for oral delivery of cyclosporine: Ne.phrotoxicity and pharmacokinetic studies in comparison to Sandimmune Neoral ®. J. Control. Release, 2007, 119(2), 197-206.
-
(2007)
J. Control. Release
, vol.119
, Issue.2
, pp. 197-206
-
-
Italia, J.L.1
Bhatt, D.K.2
Bhardwaj, V.3
Tikoo, K.4
Kumar, M.N.V.R.5
-
17
-
-
0033790335
-
Freeze-drying of polycaprolactone and poly(-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs
-
Saez, A.; Guzmán, M.; Molpeceres, J.; Aberturas, M.R. Freeze-drying of polycaprolactone and poly(-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs. Eur. J. Pharm. Biopharm., 2000, 50(3), 379-387.
-
(2000)
Eur. J. Pharm. Biopharm
, vol.50
, Issue.3
, pp. 379-387
-
-
Saez, A.1
Guzmán, M.2
Molpeceres, J.3
Aberturas, M.R.4
-
18
-
-
33646830139
-
Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage
-
Abdelwahed, W.; Degobert, G.; Fessi, H. Investigation of nanocapsules stabilization by amorphous excipients during freeze-drying and storage. Eur. J. Pharm. Biopharm., 2006, 63(2), 87-94.
-
(2006)
Eur. J. Pharm. Biopharm
, vol.63
, Issue.2
, pp. 87-94
-
-
Abdelwahed, W.1
Degobert, G.2
Fessi, H.3
-
19
-
-
67349119561
-
Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage
-
Holzer, M.; Vogel, V.; Mantele, W.; Schwartz, D.; Haase, W.; Langer, K. Physico-chemical characterisation of PLGA nanoparticles after freeze-drying and storage. Eur. J. Pharm. Biopharm., 2009, 72(2), 428-437.
-
(2009)
Eur. J. Pharm. Biopharm
, vol.72
, Issue.2
, pp. 428-437
-
-
Holzer, M.1
Vogel, V.2
Mantele, W.3
Schwartz, D.4
Haase, W.5
Langer, K.6
-
20
-
-
60049090585
-
Design of biodegradable nanoparticles for oral delivery of doxorubicin: In-vivo pharmacokinetics and toxicity studies in rats
-
Kalaria, D.R.; Sharma, G.; Beniwal, V.; Ravi Kumar, M.N. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in-vivo pharmacokinetics and toxicity studies in rats. Pharm. Res., 2009, 26(3), 492-501.
-
(2009)
Pharm. Res
, vol.26
, Issue.3
, pp. 492-501
-
-
Kalaria, D.R.1
Sharma, G.2
Beniwal, V.3
Ravi, K.M.N.4
-
21
-
-
67349107075
-
Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
-
Shaikh, J.; Ankola, D.D.; Beniwal, V.; Singh, D.; Kumar, M.N. Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer. Eur. J. Pharm. Sci., 2009, 37(3-4), 223-230.
-
(2009)
Eur. J. Pharm. Sci
, vol.37
, Issue.3-4
, pp. 223-230
-
-
Shaikh, J.1
Ankola, D.D.2
Beniwal, V.3
Singh, D.4
Kumar, M.N.5
-
22
-
-
43249085707
-
The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM)
-
Zhang, L.; Liu, L.; Qian, Y.; Chen, Y. The effects of cryoprotectants on the freeze-drying of ibuprofen-loaded solid lipid microparticles (SLM). Eur. J. Pharm. Biopharm., 2008, 69(2), 750-759.
-
(2008)
Eur. J. Pharm. Biopharm
, vol.69
, Issue.2
, pp. 750-759
-
-
Zhang, L.1
Liu, L.2
Qian, Y.3
Chen, Y.4
-
23
-
-
0037093720
-
Biocompatible stabilizers in the preparation of PLGA nanoparticles: A factorial design study
-
Vandervoort, J.; Ludwig, A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int. J. Pharm., 2002, 238(1-2), 77-92.
-
(2002)
Int. J. Pharm
, vol.238
, Issue.1-2
, pp. 77-92
-
-
Vandervoort, J.1
Ludwig, A.2
-
24
-
-
0032964174
-
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS
-
Scholes, P.D.; Coombes, A.G.A.; Illum, L.; Davis, S.S.; Watts, J.F.; Ustariz, C.; Vert, M.; Davies, M.C. Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J. Control. Release, 1999, 59(3), 261-278.
-
(1999)
J. Control. Release
, vol.59
, Issue.3
, pp. 261-278
-
-
Scholes, P.D.1
Coombes, A.G.A.2
Illum, L.3
Davis, S.S.4
Watts, J.F.5
Ustariz, C.6
Vert, M.7
Davies, M.C.8
-
25
-
-
0026468796
-
Measurements of temperatures, ice evaporation rates and residual moisture contents in freeze-drying
-
[25] Willemer, H. Measurements of temperatures, ice evaporation rates and residual moisture contents in freeze-drying. Dev. Biol. Stand., 1992, 74(123-134.
-
(1992)
Dev. Biol. Stand
, vol.74
, pp. 123-134
-
-
Willemer, H.1
-
26
-
-
0001904754
-
Freeze-drying of proteins
-
Part I: process design
-
Pikal, M.J. Freeze-drying of proteins. Part I: process design. Biopharm, 1990, 3(8), 18-27.
-
(1990)
Biopharm
, vol.3
, Issue.8
, pp. 18-27
-
-
Pikal, M.J.1
-
27
-
-
34547800192
-
Freeze-drying of nanoparticles: Formulation, process and storage considerations
-
Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freeze-drying of nanoparticles: formulation, process and storage considerations. Adv. Drug Deliv. Rev., 2006, 58(15), 1688-1713.
-
(2006)
Adv. Drug Deliv. Rev
, vol.58
, Issue.15
, pp. 1688-1713
-
-
Abdelwahed, W.1
Degobert, G.2
Stainmesse, S.3
Fessi, H.4
-
28
-
-
0027471239
-
The effect of carbohydrate additives in the freezedrying of alkaline phosphatase
-
Ford, A.W.; Dawson, P.J. The effect of carbohydrate additives in the freezedrying of alkaline phosphatase. J. Pharm. Pharmacol., 1993, 45(2), 86-93.
-
(1993)
J. Pharm. Pharmacol
, vol.45
, Issue.2
, pp. 86-93
-
-
Ford, A.W.1
Dawson, P.J.2
-
29
-
-
0030770631
-
Rational design of stable lyophilized protein formulations: Some practical advice
-
Carpenter, J.F.; Pikal, M.J.; Chang, B.S.; Randolph, T.W. Rational design of stable lyophilized protein formulations: some practical advice. Pharm. Res., 1997, 14(8), 969-975.
-
(1997)
Pharm. Res
, vol.14
, Issue.8
, pp. 969-975
-
-
Carpenter, J.F.1
Pikal, M.J.2
Chang, B.S.3
Randolph, T.W.4
-
30
-
-
0002469071
-
Preserving dry biomaterials: The water replacement hypothesis
-
Crowe, J.H.; Crowe, L.M.; Carpenter, J.F. Preserving dry biomaterials: the water replacement hypothesis. Biopharm, 1993, 6(3), 28-37.
-
(1993)
Biopharm
, vol.6
, Issue.3
, pp. 28-37
-
-
Crowe, J.H.1
Crowe, L.M.2
Carpenter, J.F.3
-
31
-
-
0032851413
-
Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method
-
Murakami, H.; Kobayashi, M.; Takeuchi, H.; Kawashima, Y. Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int. J. Pharm., 1999, 187(2), 143-152.
-
(1999)
Int. J. Pharm
, vol.187
, Issue.2
, pp. 143-152
-
-
Murakami, H.1
Kobayashi, M.2
Takeuchi, H.3
Kawashima, Y.4
-
32
-
-
0033019164
-
Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: Influence on physical stability and in vitro cell uptake
-
De Jaeghere, F.; Allemann, E.; Leroux, J.C.; Stevels, W.; Feijen, J.; Doelker, E.; Gurny, R. Formulation and lyoprotection of poly(lactic acid-co-ethylene oxide) nanoparticles: influence on physical stability and in vitro cell uptake. Pharm. Res., 1999, 16(6), 859-866.
-
(1999)
Pharm. Res
, vol.16
, Issue.6
, pp. 859-866
-
-
de Jaeghere, F.1
Allemann, E.2
Leroux, J.C.3
Stevels, W.4
Feijen, J.5
Doelker, E.6
Gurny, R.7
-
33
-
-
0031962277
-
-
Quintanar-Guerrero, D.; Ganem-Quintanar, A.; Allemann, E.; Fessi, H.; Doelker, E. Influence of the stabilizer coating layer on the purification and freeze-drying of poly(D,L-lactic acid) nanoparticles prepared by an emulsion-diffusion technique. J. Microencapsul., 1998, 15(1), 107-119.
-
(1998)
Influence of the Stabilizer Coating Layer On the Purification and Freeze-drying of Poly(D,L-lactic Acid) Nanoparticles Prepared By An Emulsion- Diffusion Technique
, vol.15
, Issue.1
, pp. 107-119
-
-
Quintanar-Guerrero, D.1
Ganem-Quintanar, A.2
Allemann, E.3
Fessi, H.4
Doelker, E.5
-
34
-
-
0021347286
-
Rheological properties of poloxamer vehicles
-
Miller, S.C.; Drabik, B.R. Rheological properties of poloxamer vehicles. Int. J. Pharm., 1984, 18(3), 269-276.
-
(1984)
Int. J. Pharm
, vol.18
, Issue.3
, pp. 269-276
-
-
Miller, S.C.1
Drabik, B.R.2
-
35
-
-
0036294121
-
Crystallization behavior of mannitol in frozen aqueous solutions
-
Cavatur, R.K.; Vemuri, N.M.; Pyne, A.; Chrzan, Z.; Toledo-Velasquez, D.; Suryanarayanan, R. Crystallization behavior of mannitol in frozen aqueous solutions. Pharm. Res., 2002, 19(6), 894-900.
-
(2002)
Pharm. Res
, vol.19
, Issue.6
, pp. 894-900
-
-
Cavatur, R.K.1
Vemuri, N.M.2
Pyne, A.3
Chrzan, Z.4
Toledo-Velasquez, D.5
Suryanarayanan, R.6
|